برای اجرای یک طرح Randomized Clinical Trial مصوب در مرکز پژوهش های دانشجویی و مرکز قلب تهران، به یک تا دو دستیار پژوهشی نیاز داریم.
🔎 Title : A Randomized Controlled Trial of HRV-Biofeedback Training on Disease Severity and Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction
✅ مشارکت های مورد نیاز:
- حضور فیزیکی در درمانگاه های تخصصی مرکز قلب تهران (صبح بعضی روز ها) برای Enrollment آزمودنی ها
- حضور فیزیکی در کلینیک برای نظارت بر مداخله Biofeedback
- کمک به آنالیز و نگارش در صورت تمایل
✅ فواید برای متقاضی:
- منجر به چاپ چندین مقاله با ذکر اسم
- ارتباط با اساتید محترم بالینی و پژوهشی مرکز قلب تهران
- ساخت رزومه و ادامه همکاری پژوهشی با پژوهشکده مرکز قلب تهران
لطفا در صورت تمایل، رزومه و انگیزه نامه (خلاصه و ساده) خود را به ایمیل یا تلگرام اینجانب ارسال کنید.
برای اجرای یک طرح Randomized Clinical Trial مصوب در مرکز پژوهش های دانشجویی و مرکز قلب تهران، به یک تا دو دستیار پژوهشی نیاز داریم.
🔎 Title : A Randomized Controlled Trial of HRV-Biofeedback Training on Disease Severity and Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction
✅ مشارکت های مورد نیاز:
- حضور فیزیکی در درمانگاه های تخصصی مرکز قلب تهران (صبح بعضی روز ها) برای Enrollment آزمودنی ها
- حضور فیزیکی در کلینیک برای نظارت بر مداخله Biofeedback
- کمک به آنالیز و نگارش در صورت تمایل
✅ فواید برای متقاضی:
- منجر به چاپ چندین مقاله با ذکر اسم
- ارتباط با اساتید محترم بالینی و پژوهشی مرکز قلب تهران
- ساخت رزومه و ادامه همکاری پژوهشی با پژوهشکده مرکز قلب تهران
لطفا در صورت تمایل، رزومه و انگیزه نامه (خلاصه و ساده) خود را به ایمیل یا تلگرام اینجانب ارسال کنید.
The next bit isn’t clear, but Durov reportedly claimed that his resignation, dated March 21st, was an April Fools’ prank. TechCrunch implies that it was a matter of principle, but it’s hard to be clear on the wheres, whos and whys. Similarly, on April 17th, the Moscow Times quoted Durov as saying that he quit the company after being pressured to reveal account details about Ukrainians protesting the then-president Viktor Yanukovych. These entities are reportedly operating nine Telegram channels with more than five million subscribers to whom they were making recommendations on selected listed scrips. Such recommendations induced the investors to deal in the said scrips, thereby creating artificial volume and price rise. On December 23rd, 2020, Pavel Durov posted to his channel that the company would need to start generating revenue. In early 2021, he added that any advertising on the platform would not use user data for targeting, and that it would be focused on “large one-to-many channels.” He pledged that ads would be “non-intrusive” and that most users would simply not notice any change. Telegram has gained a reputation as the “secure” communications app in the post-Soviet states, but whenever you make choices about your digital security, it’s important to start by asking yourself, “What exactly am I securing? And who am I securing it from?” These questions should inform your decisions about whether you are using the right tool or platform for your digital security needs. Telegram is certainly not the most secure messaging app on the market right now. Its security model requires users to place a great deal of trust in Telegram’s ability to protect user data. For some users, this may be good enough for now. For others, it may be wiser to move to a different platform for certain kinds of high-risk communications. Since its launch in 2013, Telegram has grown from a simple messaging app to a broadcast network. Its user base isn’t as vast as WhatsApp’s, and its broadcast platform is a fraction the size of Twitter, but it’s nonetheless showing its use. While Telegram has been embroiled in controversy for much of its life, it has become a vital source of communication during the invasion of Ukraine. But, if all of this is new to you, let us explain, dear friends, what on Earth a Telegram is meant to be, and why you should, or should not, need to care.
from ye
